DexTech Medical
Pre-clinicalDexTech is a Swedish research company specializing in drug development for urological oncology, primarily prostate cancer. Drug candidates are developed
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $5M
About
DexTech is a Swedish research company specializing in drug development for urological oncology, primarily prostate cancer. Drug candidates are developed
Small Molecules
Funding History
2Total raised:$5M
Seed$3MJan 15, 2020
Grant$2MMar 15, 2019